267 related articles for article (PubMed ID: 25916722)
21. Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes.
Fiedler B; Lohmann SM; Smolenski A; Linnemuller S; Pieske B; Schroder F; Molkentin JD; Drexler H; Wollert KC
Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11363-8. PubMed ID: 12177418
[TBL] [Abstract][Full Text] [Related]
22. The natriuretic peptides BNP and CNP increase heart rate and electrical conduction by stimulating ionic currents in the sinoatrial node and atrial myocardium following activation of guanylyl cyclase-linked natriuretic peptide receptors.
Springer J; Azer J; Hua R; Robbins C; Adamczyk A; McBoyle S; Bissell MB; Rose RA
J Mol Cell Cardiol; 2012 May; 52(5):1122-34. PubMed ID: 22326431
[TBL] [Abstract][Full Text] [Related]
23. Microdomain switch of cGMP-regulated phosphodiesterases leads to ANP-induced augmentation of β-adrenoceptor-stimulated contractility in early cardiac hypertrophy.
Perera RK; Sprenger JU; Steinbrecher JH; Hübscher D; Lehnart SE; Abesser M; Schuh K; El-Armouche A; Nikolaev VO
Circ Res; 2015 Apr; 116(8):1304-11. PubMed ID: 25688144
[TBL] [Abstract][Full Text] [Related]
24. Antihypertrophic actions of the natriuretic peptides in adult rat cardiomyocytes: importance of cyclic GMP.
Rosenkranz AC; Woods RL; Dusting GJ; Ritchie RH
Cardiovasc Res; 2003 Feb; 57(2):515-22. PubMed ID: 12566124
[TBL] [Abstract][Full Text] [Related]
25. Natriuretic peptides increase beta1-adrenoceptor signalling in failing hearts through phosphodiesterase 3 inhibition.
Qvigstad E; Moltzau LR; Aronsen JM; Nguyen CH; Hougen K; Sjaastad I; Levy FO; Skomedal T; Osnes JB
Cardiovasc Res; 2010 Mar; 85(4):763-72. PubMed ID: 19900965
[TBL] [Abstract][Full Text] [Related]
26. Natriuretic peptides block synaptic transmission by activating phosphodiesterase 2A and reducing presynaptic PKA activity.
Hu F; Ren J; Zhang JE; Zhong W; Luo M
Proc Natl Acad Sci U S A; 2012 Oct; 109(43):17681-6. PubMed ID: 23045693
[TBL] [Abstract][Full Text] [Related]
27. Intracellular cGMP may promote Ca2+-dependent and Ca2+-independent release of catecholamines from sympathetic nerve terminals.
Whalen EJ; Saurer TB; Johnson AK; Lewis SJ
Vascul Pharmacol; 2006 Aug; 45(2):102-11. PubMed ID: 16697265
[TBL] [Abstract][Full Text] [Related]
28. Significance and therapeutic potential of the natriuretic peptides/cGMP/cGMP-dependent protein kinase pathway in vascular regeneration.
Yamahara K; Itoh H; Chun TH; Ogawa Y; Yamashita J; Sawada N; Fukunaga Y; Sone M; Yurugi-Kobayashi T; Miyashita K; Tsujimoto H; Kook H; Feil R; Garbers DL; Hofmann F; Nakao K
Proc Natl Acad Sci U S A; 2003 Mar; 100(6):3404-9. PubMed ID: 12621153
[TBL] [Abstract][Full Text] [Related]
29. Cyclic guanosine monophosphate responses to atrial natriuretic factor, brain natriuretic peptide, but not C-type natriuretic peptide, and the characterization of their receptors in rat medullary thick ascending limb.
Luk JK; Wong EF; Sun A; Wong NL
Metabolism; 1994 Dec; 43(12):1531-5. PubMed ID: 7990707
[TBL] [Abstract][Full Text] [Related]
30. Noradrenergic cell specific gene transfer with neuronal nitric oxide synthase reduces cardiac sympathetic neurotransmission in hypertensive rats.
Li D; Wang L; Lee CW; Dawson TA; Paterson DJ
Hypertension; 2007 Jul; 50(1):69-74. PubMed ID: 17515453
[TBL] [Abstract][Full Text] [Related]
31. Role of endogenous atrial natriuretic peptide in DOCA-salt hypertensive rats. Effects of a novel nonpeptide antagonist for atrial natriuretic peptide receptor.
Hirata Y; Matsuoka H; Suzuki E; Hayakawa H; Sugimoto T; Matsuda Y; Morishita Y; Kangawa K; Minamino N; Matsuo H
Circulation; 1993 Feb; 87(2):554-61. PubMed ID: 8381060
[TBL] [Abstract][Full Text] [Related]
32. Phosphodiesterase 2 inhibition preferentially promotes NO/guanylyl cyclase/cGMP signaling to reverse the development of heart failure.
Baliga RS; Preedy MEJ; Dukinfield MS; Chu SM; Aubdool AA; Bubb KJ; Moyes AJ; Tones MA; Hobbs AJ
Proc Natl Acad Sci U S A; 2018 Jul; 115(31):E7428-E7437. PubMed ID: 30012589
[TBL] [Abstract][Full Text] [Related]
33. Dorsal root ganglion axon bifurcation tolerates increased cyclic GMP levels: the role of phosphodiesterase 2A and scavenger receptor Npr3.
Schmidt H; Peters S; Frank K; Wen L; Feil R; Rathjen FG
Eur J Neurosci; 2016 Dec; 44(12):2991-3000. PubMed ID: 27740716
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of phosphodiesterase 2 augments cGMP and cAMP signaling to ameliorate pulmonary hypertension.
Bubb KJ; Trinder SL; Baliga RS; Patel J; Clapp LH; MacAllister RJ; Hobbs AJ
Circulation; 2014 Aug; 130(6):496-507. PubMed ID: 24899690
[TBL] [Abstract][Full Text] [Related]
35. C-type natriuretic peptide increases myocardial contractility and sinus rate mediated by guanylyl cyclase-linked natriuretic peptide receptors in isolated, blood-perfused dog heart preparations.
Hirose M; Furukawa Y; Kurogouchi F; Nakajima K; Miyashita Y; Chiba S
J Pharmacol Exp Ther; 1998 Jul; 286(1):70-6. PubMed ID: 9655843
[TBL] [Abstract][Full Text] [Related]
36. Effect of cyclic GMP-increasing agents nitric oxide and C-type natriuretic peptide on bovine chromaffin cell function: inhibitory role mediated by cyclic GMP-dependent protein kinase.
Rodriguez-Pascual F; Miras-Portugal MT; Torres M
Mol Pharmacol; 1996 Jun; 49(6):1058-70. PubMed ID: 8649344
[TBL] [Abstract][Full Text] [Related]
37. Feedback control through cGMP-dependent protein kinase contributes to differential regulation and compartmentation of cGMP in rat cardiac myocytes.
Castro LR; Schittl J; Fischmeister R
Circ Res; 2010 Nov; 107(10):1232-40. PubMed ID: 20847310
[TBL] [Abstract][Full Text] [Related]
38. Neutral endopeptidase inhibition potentiates the effects of natriuretic peptides in renin transgenic rats.
Wegner M; Ganten D; Stasch JP
Hypertens Res; 1996 Dec; 19(4):229-38. PubMed ID: 8986453
[TBL] [Abstract][Full Text] [Related]
39. Adrenomedullin induces direct (endothelium-independent) vasorelaxations and cyclic adenosine monophosphate elevations that are synergistically enhanced by brain natriuretic peptide in isolated rings of rat thoracic aorta.
Fung E; Fiscus RR
J Cardiovasc Pharmacol; 2003 Jun; 41(6):849-55. PubMed ID: 12775961
[TBL] [Abstract][Full Text] [Related]
40. Ammonia inhibits the C-type natriuretic peptide-dependent cyclic GMP synthesis and calcium accumulation in a rat brain endothelial cell line.
Konopacka A; Zielińska M; Albrecht J
Neurochem Int; 2008 May; 52(6):1160-6. PubMed ID: 18222015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
